Treatment of acute lymphoblastic leukemia in adolescents and young adults. - Wikidata - wikimedia - TriplyDB

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

http://www.wikidata.org/entity/Q37899785

about

Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002 Targeted drug discovery for pediatric leukemia.Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia.

P2860

Q36805851-37DBD734-B4F4-49BE-B2D4-481B3771DF19 Q36989223-6ADCF746-1C75-4CBF-95E9-33D3E3FE008F Q39196420-A459B9C8-8187-4253-BF05-2C6F4D4402DF

P2860

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

http://www.wikidata.org/entity/Q37899785

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@en

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@nl

type

label

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@en

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@nl

prefLabel

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@en

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@nl

P1433

Q37899785-F8D82647-6513-4DB6-9B9F-948F3EA96516

P1476

Q37899785-BE23EF40-B5CA-4D1F-A33F-9F80452DDC65

P2093

Q37899785-104D0605-5938-4DC5-AF7A-FD602E00628C

P2860

Q37899785-033F839B-1A43-4604-A547-B6FA2385ED92

Q37899785-0D8AF597-55F0-4DD1-B153-9F53D2B15F85

Q37899785-18FEFEDE-F773-484D-970E-64ADED36517A

Q37899785-1E541D1F-7845-44F1-9640-6348E57646BF

Q37899785-1E5598B7-301E-4555-9B80-1F54116B0AB4

Q37899785-20810C83-8041-429C-9985-F23BF7142A8F

Q37899785-24D653A4-A72B-4B78-B566-E0736CEC4A40

Q37899785-25B84841-247F-442E-B375-59D414C0159D

Q37899785-2D5B5891-DC70-4E51-BA5B-03E4308D94D3

Q37899785-2E073954-C2F5-4D9A-B1E0-8771598B54C8

P2888

Q37899785-F8196C77-20D7-465A-BE40-4B6E0EC02898

P304

Q37899785-471FE89E-1514-444C-8A87-A22B4205A0DB

P31

Q37899785-8874C69A-7B93-4F23-8378-0AA56901A1B9

P356

Q37899785-381D9C70-E297-49E0-A161-41E0BE2189FA

P433

Q37899785-D10E79BB-3486-4694-89F3-FCC8360B3162

P478

Q37899785-98F6983F-F571-4226-94C4-F1BD3384861F

P577

Q37899785-DC48D805-72AB-42AB-A43D-AEC63B3CF6C9

P5875

Q37899785-57DAB5FA-2A25-4378-921D-F8EC20481821

P698

Q37899785-56D10BDF-ED09-4E82-B950-38C44C3E1B14

P921

Q37899785-726F153E-A18E-41AA-BD68-AB1896C55072

Q37899785-7D203C00-A7FD-4841-887E-BE6A2C5469E8

P356

S11912-011-0185-9

P1433

Current Oncology Reports

P1476

Treatment of acute lymphoblastic leukemia in adolescents and young adults.

@en

P2093

Joseph M Brandwein

http://www.w3.org/2001/XMLSchema#string

P2860

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International

Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.

P2888

s11912-011-0185-9

P304

371-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-011-0185-9

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51481586

http://www.w3.org/2001/XMLSchema#string

P698

21744057

http://www.w3.org/2001/XMLSchema#string

P921